さらに表示 Biotech イベント
Join us at a location near you to meet our experts and product specialists, and learn out how the latest technical innovations can improve both the efficiency and quality of your processes at all scales.
October 2019
BioJapan 2019

パシフィコ横浜 展示ホール, 横浜

BioJapanは1986年の初開催から成長を続け、21回目の開催を迎えます。創薬、個別化医療、再生医療、診断・医療機器、ヘルスケア、環境・エネルギー、機能性食品、研究用機器・試薬等の分野において、34ヶ国から1000社以上の参加が見込まれます。
展示会・セミナー・パートナリングプログラムを通じてバイオ産業のオープンイノベーションを加速させます(公式ページより)。

ポール・バイオテックでは連続生産、バイオリアクター、シングルユース製品などの展示の他、出展社プレゼンテーションも行います。

出展社プレゼンテーションでは、パーフュージョン培養に対応する清澄化の連続技術についてご紹介する予定です。

詳細が決まり次第、お知らせいたします。

September 2019
1st Annual Biologics Manufacturing Japan 2019

シェラトン都ホテル東京 醍醐西 , 東京

日本初開催の国際カンファレンスです。

同じ会場で3rd Annual Cell Therapy World Asia Conferenceも同時開催され、世界各国からバイオ医薬品に関わる企業が参加します。

製薬会社、規制当局、アカデミアから様々なスピーカーを招き、業界のトレンド、ベストプラクティス、最新技術の紹介が行われるほか、懇親会でのネットワーキングも行えます。

ポール・バイオテックの製品も会場で展示いたします。奮ってご参加ください。

展示詳細は決まり次第、お知らせします。

 

July 2019
第25回日本遺伝子細胞治療学会(JSGCT2019)

東京大学本郷キャンパス(安田講堂、他構内施設), 文京区、東京

今年は東京大学の藤堂 具紀教授が大会長を務め、「日本発の成果を世界の治療に―Delivering Original Therapies from Japan to The World」をテーマに、産官学どの立場からも世界情勢を把握し、今後の遺伝子細胞治療に発展につながる学術集会です。

ポールは接着細胞用バイオリアクターiCELLis nanoの展示だけではなく、7月21日(日)に開催する「Evening seminar」にてAAVに関する講演を行う予定です。

インターフェックスジャパン 2019

東京ビッグサイト, 東京

セミナー日時決定!!

【出展社による製品・技術セミナー】 

■日時:2019年7月3日(水) 12:20 - 13:20 

■演者:針金谷 尚人 - 日本ポール株式会社 バイオテック事業部 ビジネスディベロップメントマネージャー 

■講演タイトル:遺伝子治療用ウイルスベクター製造のためのソリューション 

■講演内容:培養から精製まで一貫したスケーラビリティのある製造技術について、海外の事例を交えた最新情報を紹介する。

 

【第3回バイオ医薬EXPO 専門セミナー 】

■日時:2019年7月5日(金)9:30-10:30

■演者:山川 大介 - 日本ポール株式会社 バイオテック事業部 第一営業ユニット バイオプロセススペシャリストグループ グループリーダー

■講演タイトル:バイオ医薬品製造におけるシングルユース技術―現状と未来―

■講演内容:現在のバイオ医薬品の開発・製造において、シングルユース技術は不可欠なものとなっている。本公演ではシングルユース技術の特長を活かした最新の運用方法から、今後普及が見込まれる技術として注目されている連続生産まで、ポール社の取り組みを紹介する。 

 

展示詳細は決まり次第、お知らせします。 

March 2019
第18回日本再生医療学会総会

神戸国際展示場, 神戸市

展示製品

iCELLis® Bioreactor

SoloHill® Microcarriers

Xpansion® Multiplate Bioreactor System

Sterile Connector

Mustang 

November 2017
Pharmtech 2017

Crocus Expo IEC, Moscow

Join us at the Pharmtech exhibition to discover our most recent advances in continuous bioprocessing. Visit us at booth #A429, Hall 7, for a week of expert knowledge, cutting-edge technology and critical learning, all delivered with news of the latest industry trends and breakthroughs in science and technology.
 

Pharmtech & Ingredients is the largest international exhibition in Russia and the CIS presenting equipment, raw materials and technologies for manufacturing pharmaceutical products, nutritional supplements, blood products and cosmetics. It gives companies – producers and suppliers – a unique opportunity to present modern production and packaging equipment, laboratory equipment, projects and technological solutions for turnkey pharmaceutical manufacturing, for cleanrooms and for clinical trials conduction.

The Ingredients sector is intended to reflect the increased role of high quality active pharmaceutical ingredients and functional ingredients for producing modern medicines.

Pall has turned continuous bioprocessing theory into reality. Only Pall has the Continuous Ready products and integration expertise that has made Continuous Bioprocessing a reality. They enable bioprocessors to achieve the highest product quality, productivity and patient benefit with a dramatically smaller footprint and shorter lead times.

We look forward to meeting you!

Products Featured
Cadence Acoustic Separator
Kleenpak® Presto Sterile Connector
Cadence™ Inline Concentrator
iCELLis® Bioreactor

Leadership Forum on Bioprocess Intensification

DoubleTree by Hilton Hotel, Westborough, MA

Pall Life Sciences invites you to join industry leaders for two days of expert knowledge, cutting-edge technology and critical learning. All delivered with industry case studies, latest industry trends and breakthroughs in science and technology.

AGENDA


Tuesday, November 14th

12:00 pm - 1:30 pm

Registration and Networking Lunch
 

1:30 pm -1:40 pm

Welcome and Introduction
 

1:40 pm - 2:10 pm

‘An Update on Significant Technology Advances Enabling Integrated Continuous Bioprocessing’
 

2:10 pm - 3:55 pm

‘Making a Business Case for Integrated Process Technology’
 

3:55 pm -4:25 pm

Break – Posters
 

4:25 pm - 6:10 pm

Workshop: 3 Technology Sessions Running in Parallel (40 Minutes/Workshop)
 

6:10 pm - 6:20 pm

Summary and End of Day 1
 

7:15 pm

Departure from DoubleTree Hotel
 

7:45 pm

Dinner
 

11:00 pm

Return to DoubleTree Hotel


Wednesday, November 15th

8:15 am - 8:30 am
Welcome

8:30 am - 10:15 am

‘Experiences About Processing and Technology Challenges From Batch to Continuous’
 

10:15 am - 10:45 am

Break – Posters
 

10:45 am - 2:30 pm

Roundtable - Applying ICH Q8/Q9 to Continuous Processing
 

12:30 pm - 13:00 pm

Drivers for an Evaluation of Continuous Capture Chromatography at KBI Biopharma
 

13:00 pm - 13:05 pm

Event Summary and Closing
 

13:05 pm - 14:30 pm

Networking Lunch
 


Download the full agenda

Swiss Cleanroom Concept

Courtyard Marriott, PratteIn

Join us at this event to discover our total mixing solutions at this Swiss Cleanroom Community Event, the meeting place of the GMP and cleanroom sectors, held twice a year for knowledge transfer, product information and networking. The education and networking in this stimulating atmosphere are the success of the event.

We will take this opportunity to present you our total mixing solutions - a critical operation within many biopharmaceutical processes for applications ranging from buffer and media preparation, in-process unit operations such as low pH viral inactivation to final formulation.

Pall provides the broadest range of single-use mixers, covering all potential applications and requirements. Our magnetic drive technologies (Magnetic and LevMixer® units) represent the foundation of the largest installed base of mixing technology globally.

With our automation expertise and complementary technologies such as the Pall powder transfer bags and the Allegro™ MVP system, we can provide full automation around mixing applications with our standard systems, or customized solutions. 


We look forward to meeting you!

Products Featured
Single-Use Mixers

October 2017

Join us during this day of professional growth, discussion and update on the main trend of Advanced Therapy Medicinal Products.


Agenda

  • Developing T-cell therapy program
  • “Hospital Exemption”
  • Neural stem cells in MS: from bench to bedside
  • CAR-T industrialization
  • Clinical applications of MSCs in HSCT and beyond
  • Latest advances for CARCIK.CD19 clinical protocol
  • Bioreactors for viral vectors manufacturing
  • Regulatory perspective



13:00 – 14:00

Presentation: Lentiviral/Retroviral Vector Manufacturing Production using iCELLis® Disposable Fixed-Bed Bioreactor iCELLis System"
Manuela Cota, Upstream Vector Development Supervisor, MolMed S.p.a. (Italy)


Abstract
Lentiviral vectors (LVV), produced with transient quadri-transfection in 293T adhesion cell line and retroviral vectors (RVV), produced with a stable packaging cell line, are used in gene therapy studies. In the context of advanced clinical studies or commercial phase, an important manufacturing challenge is the optimization of vector production in large-scale platforms. To address this issue and to obtain a scalable and robust process, development studies were performed using iCELLis fixed-bed disposable bioreactors. 

The optimized parameters included seeding cell density, DNA concentration, transfection agents, timing and volumes of harvest. Final vectors were characterized for infectious viral titer (TU/mL), particle content (ng p24 or ng p30), process related impurities and then compared to vectors produced by current GMP processes based on Cell Factories (CFs).

Productivity was 5.7 x 106 TU/mL with an infectivity of 6 x 104 TU/ng p30 and 3.1 x 107 TU/mL with an infectivity of 8 x 104 TU/ng p24 for RVV and LVV, respectively. Productivity using bioreactors was higher than that obtained in GMP CFs based processes while impurities profiles (BSA, HCD, HCP) were overall comparable. Vectors manufactured in bioreactor were used to transduce primary cells (CD34+ and T cells) showing high transduction efficiency and vector copy number. Although the downstream process currently in use for GMP LVV production can be successfully applied to vectors produced in small scale bioreactors, a different strategy is under development to accommodate larger volumes. Preliminary data indicate the possibility to efficiently purify vectors with no detrimental impact on process performance, vector infectivity and stability.

 

Products Featured
iCELLis® Bioreactor
Xpansion® Multiplate Bioreactor System
PadReactor® Mini Bioreactor
SoloHill® Microcarriers 

The ESGCT Annual Meeting provides an opportunity for scientists, clinicians and industry professionals to share new data, learn from peers, and discover global advances within the Gene and Cell Therapy field. 

 

Pall's cell therapy technologies and services include powerful manufacturing platforms designed to help you overcome the challenges associated with producing live cells destined for therapeutics, and streamline your pathway to commercialization in these very exciting applications. 

 

Our business philosophy and culture are centered on helping our customers achieve their goals. Together, our combined expertise is advancing the development of cell therapies that will improve the lives of patients worldwide. 

 

We look forward to meeting you!

Products Featured
Xpansion® Multiplate Bioreactor System
iCELLis® Bioreactor
SoloHill® Microcarriers
Allegro™ Unison hMSCs and Media